News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
India’s Strides Arcolab Limited Ends Joint Venture with ACCU-BREAK Pharmaceuticals, Inc.
May 2, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MUMBAI, May 2 (Reuters) - India's Strides Arcolab Ltd. (STAR.BO: Quote, Profile , Research) said on Wednesday it had terminated a joint venture agreement with ACCU-BREAK Pharmaceuticals Inc., citing changes in the U.S. company's business model.
>>>
Discuss This Story
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Asia
MORE ON THIS TOPIC
Artificial intelligence
AstraZeneca Makes $5.3B AI Bet With China’s CSPC for Chronic Disease Pills
June 13, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
BioNTech Swallows Vaccine Rival CureVac in $1.25B All-Stock Acquisition
June 12, 2025
·
3 min read
·
Tristan Manalac
Layoffs
Genentech Lays Off 143 Employees in South San Francisco Reshuffle
June 11, 2025
·
1 min read
·
Dan Samorodnitsky
Deals
BMS Expands Radiopharma Presence With $1.35B Biobucks Deal for Philochem
June 11, 2025
·
2 min read
·
Tristan Manalac